Vaidya Sane Ayurved Laboratories Ltd

Vaidya Sane Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vaidya Sane Ayurved Laboratories Ltd

₹ 283 2.91%
17 Nov - close price
madhavbaug.org NSE - SME: MADHAVBAUG
About

Incorporated in 2006, Vaidya Sane Ayurved Laboratories Ltd is the business of running
of hospitals & clinics, and sale of Ayurved based medicines[1]

Key Points

Business Overview[1]
Vaidya Sane Ayurved Laboratories Ltd (Madhavbaug) is among India’s leading chains of cardiac care clinics and hospitals, specializing in non-invasive, Ayurveda-based treatments for chronic conditions like heart disease, diabetes, hypertension, obesity, and joint pain. The company combines traditional medicine with modern diagnostics and technology, supported by in-house manufacturing of Ayurvedic medicines and nutritional products.

Website NSE - SM
  • Market Cap ₹ 298 Cr.
  • Current Price ₹ 283
  • High / Low ₹ 313 / 81.1
  • Stock P/E 33.1
  • Book Value ₹ 64.4
  • Dividend Yield 0.00 %
  • ROCE 18.4 %
  • ROE 13.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 4.39 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Edit Columns
Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025
45.59 53.58 51.10 48.23 41.80 48.05 49.94
41.43 49.90 48.41 46.41 36.03 40.34 41.32
Operating Profit 4.16 3.68 2.69 1.82 5.77 7.71 8.62
OPM % 9.12% 6.87% 5.26% 3.77% 13.80% 16.05% 17.26%
0.83 0.54 0.63 1.12 0.83 -0.18 0.95
Interest 0.11 0.07 0.16 0.09 0.08 0.03 0.10
Depreciation 1.16 1.44 1.59 1.56 1.77 2.39 3.00
Profit before tax 3.72 2.71 1.57 1.29 4.75 5.11 6.47
Tax % 26.61% 22.51% 24.84% 37.21% 20.84% 34.64% 25.19%
2.73 2.09 1.18 0.80 3.76 3.38 4.83
EPS in Rs 2.60 1.99 1.12 0.76 3.58 3.21 4.59
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 TTM
99.17 99.32 89.85 97.99
90.64 93.94 76.36 81.66
Operating Profit 8.53 5.38 13.49 16.33
OPM % 8.60% 5.42% 15.01% 16.66%
1.36 1.75 0.66 0.77
Interest 0.86 1.12 0.10 0.13
Depreciation 2.60 3.14 4.16 5.39
Profit before tax 6.43 2.87 9.89 11.58
Tax % 24.88% 30.31% 27.70%
4.83 1.98 7.14 8.21
EPS in Rs 4.59 1.88 6.79 7.80
Dividend Payout % 5.44% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 9%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 97%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 26%
1 Year: 91%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 10.51 10.51 10.52 10.52
Reserves 29.94 45.09 52.03 57.22
0.13 1.68 1.46 0.63
14.30 13.61 12.76 13.64
Total Liabilities 54.88 70.89 76.77 82.01
20.95 28.02 34.92 33.93
CWIP 1.67 2.60 0.00 0.33
Investments 15.33 3.22 21.34 21.74
16.93 37.05 20.51 26.01
Total Assets 54.88 70.89 76.77 82.01

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
0.06 -4.41 10.60
0.52 1.49 -10.08
-1.38 14.46 -0.54
Net Cash Flow -0.80 11.55 -0.01

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
Debtor Days 22.05 26.31 32.25
Inventory Days 81.93
Days Payable 142.73
Cash Conversion Cycle 22.05 26.31 -28.54
Working Capital Days -2.39 0.66 42.94
ROCE % 7.44% 18.45%

Shareholding Pattern

Numbers in percentages

Mar 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Sep 2024Mar 2025Sep 2025
66.34% 66.34% 66.34% 66.34% 66.34% 66.34% 66.34% 66.34% 66.34% 66.34% 66.34%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.21%
33.67% 33.66% 33.68% 33.67% 33.67% 33.66% 33.66% 33.66% 33.66% 33.66% 33.45%
No. of Shareholders 493464534595637731846881821787712

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls